TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35025156

Group type: EXPERIMENTAL
Intervention: Acupuncture‐moxibustion group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Acupuncture group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Moxibustion group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Medication group
Number of subjects: 120
Study: 32901709

Group type: EXPERIMENTAL
Intervention: Occlusal adjustment group (OAG)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 78
Study: 35505455

Group type: EXPERIMENTAL
Intervention: Loss-framing with proximal temporal framing
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Gain-framing with proximal temporal framing
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Loss-framing with distal temporal framing
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Gain-framing with distal temporal framing
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Temporal framing and gain-loss framing interaction
Number of subjects: 114
Study: 34368892

Group type: EXPERIMENTAL
Intervention: gPVG food pattern (general pro-vegetarian food pattern)
Number of subjects: 6439

Group type: EXPERIMENTAL
Intervention: hPVG food pattern (healthful pro-vegetarian food pattern)
Number of subjects: 6439

Group type: EXPERIMENTAL
Intervention: uPVG food pattern (unhealthful pro-vegetarian food pattern)
Number of subjects: 6439
Study: 35833597

Group type: EXPERIMENTAL
Intervention: Liraglutide (1.2 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 33217070

Group type: EXPERIMENTAL
Intervention: Pep-Pal (n = 26)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Treatment as usual (TAU; n = 30)
Number of subjects: 56
Study: 32433419

Group type: EXPERIMENTAL
Intervention: Histologically-confirmed NASH patients
Number of subjects: 14403

Group type: EXPERIMENTAL
Intervention: Patients with NASH
Number of subjects: 14403
Study: 32469305

Group type: EXPERIMENTAL
Intervention: Test formulation of acetylsalicylic acid (81 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference formulation of acetylsalicylic acid (Ecasil-81, 81 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Food intake during administration
Number of subjects: 48
Study: 32979027

Group type: EXPERIMENTAL
Intervention: Mindfulness training
Number of subjects: 300
Study: 34119240

Group type: EXPERIMENTAL
Intervention: Bacillus coagulans SNZ 1969 (BC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32297840

Group type: EXPERIMENTAL
Intervention: Approximation methods for EVSI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional Monte Carlo method
Number of subjects: 0
Study: 616063739

Group type: EXPERIMENTAL
Intervention: Intermediate or full doses of epirubicin-cyclophosphamide
Number of subjects: 734

Group type: COMPARATOR
Intervention: Cyclophosphamide, methotrexate and 5-fluorouracil
Number of subjects: 734
Study: 35457425

Group type: EXPERIMENTAL
Intervention: Normobaric acute hypoxia (HYPO)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normoxia (NORMO)
Number of subjects: 22
Study: 34710105

Group type: EXPERIMENTAL
Intervention: Local-ingredients-based supplement (LIBS)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Corn-soy blend plus (CSB+)
Number of subjects: 324
Study: 32366320

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy self-help (MBCT-SH)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Cognitive behavioural therapy self-help (CBT-SH)
Number of subjects: 410
Study: 35325665

Group type: EXPERIMENTAL
Intervention: Burst physical therapy (two PT sessions weekly for 6 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Spaced physical therapy (one PT session every 2 weeks for 6 months)
Number of subjects: 30
Study: 32186653

Group type: EXPERIMENTAL
Intervention: 81 mg of aspirin daily
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: 325 mg of aspirin daily
Number of subjects: 15000
Study: 35897022

Group type: EXPERIMENTAL
Intervention: mHealth intervention group (activity tracker wristband, SMS reminders, counselling with diabetes specialist nurse)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (counselling with diabetes specialist nurse only)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: mHealth intervention group
Number of subjects: 142
Study: 34190186

Group type: EXPERIMENTAL
Intervention: Catheter-over-needle (CON) method
Number of subjects: 70

Group type: COMPARATOR
Intervention: Catheter-through-needle (CTN) method
Number of subjects: 70
Study: 33977310

Group type: EXPERIMENTAL
Intervention: Full-length tibial anatomic axis measurements
Number of subjects: 200

Group type: COMPARATOR
Intervention: Half-length tibial anatomic axis measurements
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Comparison of PTS measurements
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Correlation between PTS measurements
Number of subjects: 200
Study: 34610846

Group type: EXPERIMENTAL
Intervention: Mobile-app-based instruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34170477

Group type: EXPERIMENTAL
Intervention: Liver enzymes (ALT)
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: Liver enzymes (AST)
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: ALT ≥ 40
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: AST ≥ 40
Number of subjects: 952
Study: 33989324

Group type: EXPERIMENTAL
Intervention: Verbal Information Session (IS)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Verbal Information Session with Slideshow
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Verbal Information Session followed by Theater
Number of subjects: 604

Group type: COMPARATOR
Intervention: Informed Consent Form (ICF) only
Number of subjects: 604
Study: 35873227

Group type: EXPERIMENTAL
Intervention: Meaning-Centered Psychotherapy (MCP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study: 33001764

Group type: COMPARATOR
Intervention: Preoperative capecitabine-based chemoradiation (45-50.4 Gy) followed by six cycles of adjuvant capecitabine without oxaliplatin (control arm)
Number of subjects: 1068

Group type: EXPERIMENTAL
Intervention: Preoperative capecitabine-based chemoradiation (45-50.4 Gy) followed by six cycles of adjuvant capecitabine with oxaliplatin (experimental arm)
Number of subjects: 1068
Study: 32861275

Group type: EXPERIMENTAL
Intervention: COVID-19 ARDS patients
Number of subjects: 39
Study: 35561315

Group type: EXPERIMENTAL
Intervention: Iptacopan 25 mg for 4 weeks followed by 100 mg for up to 2 years (cohort 1)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Iptacopan 50 mg for 4 weeks followed by 200 mg for up to 2 years (cohort 2)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Iptacopan (both cohorts)
Number of subjects: 13
Study: 33243471

Group type: EXPERIMENTAL
Intervention: Group B (BioHorizons)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group N (NucleOSS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control subgroup (NucleOSS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.6 mm wall thickness subgroup (NucleOSS)
Number of subjects: 60
Study: 33177265

Group type: EXPERIMENTAL
Intervention: Dramatic performance by a professional actor, performed for one and half hours once per week for 3 months.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no dramatic performance).
Number of subjects: 34

Group type: COMPARATOR
Intervention: Both groups received treatment for BPSD.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Dramatic performance group vs Control group.
Number of subjects: 34
Study: 35105620

Group type: EXPERIMENTAL
Intervention: WHO mental health Gap Action Programme primary care mental health training intervention (10-day training)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Tailored training intervention for public health professionals and community representatives
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Refresher courses at 3 and 6 months post training
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Supervision and monitoring for 1 month pre and post training
Number of subjects: 23
Study: 32764111

Group type: EXPERIMENTAL
Intervention: Asthma patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (OCS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: General population
Number of subjects: 0
Study: 34206292

Group type: EXPERIMENTAL
Intervention: Web-based educational program on physical restraint reduction
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 169
Study: 32188768

Group type: EXPERIMENTAL
Intervention: VR training with a VR application and headset to view stereoscopic surgical videos
Number of subjects: 44

Group type: COMPARATOR
Intervention: Traditional methods (control group) including lectures, videos, and skills practice on models
Number of subjects: 44
Study: 35499664

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35192438

Group type: EXPERIMENTAL
Intervention: Remote
Number of subjects: 332

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 332
Study: 33888139

Group type: EXPERIMENTAL
Intervention: Ceftolozane-tazobactam 3 g every 8 hours
Number of subjects: 600

Group type: COMPARATOR
Intervention: Meropenem 1 g every 8 hours
Number of subjects: 600
Study: 32506940

Group type: EXPERIMENTAL
Intervention: Intradialytic cycling exercise for 12 weeks
Number of subjects: 76
Study: 34415265

Group type: EXPERIMENTAL
Intervention: lenadogene nolparvovec (rAAV2/2‐ND4)
Number of subjects: 76
Study: 35403225

Group type: EXPERIMENTAL
Intervention: Senicapoc (50 mg enteral) administered as soon as possible after randomization and again after 24 hours.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard care only (control group).
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Senicapoc (50 mg enteral).
Number of subjects: 46
Study: 32722776

Group type: EXPERIMENTAL
Intervention: Component Dorsal Hump Reduction group (CDRg)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Spare Roof Technique group (SRTg)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Both techniques (CDRg and SRTg)
Number of subjects: 250
Study: 36285404

Group type: EXPERIMENTAL
Intervention: Targeted oral naltrexone (50 mg) with weekly counseling for 12 weeks
Number of subjects: 120
Study: 33507146

Group type: EXPERIMENTAL
Intervention: RIF-resistant isolates (n=105)
Number of subjects: 195

Group type: COMPARATOR
Intervention: RIF-sensitive isolates (n=90)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: RIF-resistant/RFB-resistant strains (n=105)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: RIF-resistant/RFB-sensitive strains (n=105)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Novel deletion mutation (ATCATGCAT) in RIF-resistant strains
Number of subjects: 195
Study: 34045905

Group type: EXPERIMENTAL
Intervention: 250 mg WDTE60N capsule (150 mg curcuminoids)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 96
Study: 36363506

Group type: COMPARATOR
Intervention: Custom insole with minimalist flexible shoes (CIG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Minimalist flexible shoes alone (SG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Custom insole with minimalist flexible shoes (CIG) and Minimalist flexible shoes alone (SG)
Number of subjects: 36
Study: 35212740

Group type: EXPERIMENTAL
Intervention: High-protein and fiber-based multi-ingredient nutritional shake (HPF) (17 g protein, 6 g fiber)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Low-protein, lower fiber-based placebo (LPF) (1 g protein, 3 g fiber)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: High-protein and fiber-based multi-ingredient nutritional shake (HPF)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Low-protein, lower fiber-based placebo (LPF)
Number of subjects: 206
Study: 32436641

Group type: EXPERIMENTAL
Intervention: Ultra rapid lispro (URLi)
Number of subjects: 68
Study: 35318120

Group type: EXPERIMENTAL
Intervention: GnRH antagonist protocol with high LH levels on day six
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: GnRH antagonist protocol with low LH levels on day six
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: GnRH antagonist protocol with medium LH levels on day six
Number of subjects: 109

Group type: COMPARATOR
Intervention: GnRH antagonist protocol
Number of subjects: 109
Study: 36273991

Group type: EXPERIMENTAL
Intervention: Per-oral pancreatoscopy-guided lithotripsy (POP)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Extracorporeal shock wave lithotripsy (ESWL)
Number of subjects: 150
Study: 35405168

Group type: EXPERIMENTAL
Intervention: ChAd/ChAd/BNT162b2 (Pfizer-BioNtech)
Number of subjects: 2422

Group type: EXPERIMENTAL
Intervention: Ad26.COV2.S (Janssen)
Number of subjects: 2422

Group type: COMPARATOR
Intervention: BNT (15 μg)
Number of subjects: 2422

Group type: COMPARATOR
Intervention: BNT/BNT
Number of subjects: 2422
Study: 32772737

Group type: COMPARATOR
Intervention: Oral medications (including voltage‐gated calcium channels antagonists, voltage‐gated sodium channel antagonists, serotonin‐norepinephrine reuptake inhibitors, NMDA antagonists)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 37349498

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg/Paracetamol 1000 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg/Paracetamol 1000 mg/Codeine 60 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Paracetamol 1000 mg/Codeine 60 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 34432989

Group type: EXPERIMENTAL
Intervention: Active Early Learning (AEL) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33141092

Group type: EXPERIMENTAL
Intervention: DHealthBar mobile-based intervention (WeChat applet)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Printed educational materials
Number of subjects: 79
Study: 35397474

Group type: EXPERIMENTAL
Intervention: Chemical harms warning message
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Lung harms warning message
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: COVID-19 harms warning message
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Nicotine addiction warning message
Number of subjects: 623

Group type: COMPARATOR
Intervention: Control (messages about vape litter)
Number of subjects: 623
Study: 33295397

Group type: EXPERIMENTAL
Intervention: Lactobacillus Plantarum probiotic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 36501014

Group type: EXPERIMENTAL
Intervention: l-arginine plus vitamin C
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32740409

Group type: EXPERIMENTAL
Intervention: Aliskiren (150 mg once daily, n=9)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ramipril (5 mg once daily, n=7)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aliskiren (150 mg once daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Aliskiren and Ramipril
Number of subjects: 16
Study: 32881865

Group type: EXPERIMENTAL
Intervention: Insecticide-treated materials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34244257

Group type: EXPERIMENTAL
Intervention: Partially covered self-expandable metal stent (PCSEMS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Uncovered self-expandable metal stent (USEMS)
Number of subjects: 100
Study: 32943383

Group type: EXPERIMENTAL
Intervention: Distal clavicle resection (DCR) during arthroscopic rotator cuff repair
Number of subjects: 200
Study: 615916899

Group type: EXPERIMENTAL
Intervention: Glasses
Number of subjects: 117

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 117
Study: 35943324

Group type: EXPERIMENTAL
Intervention: Conventional double‐puncture arthrocentesis
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Single‐puncture type 2 arthrocentesis
Number of subjects: 26
Study: 33112363

Group type: EXPERIMENTAL
Intervention: Home-based mobile cardiac rehabilitation (MCR) for 6 months with telemonitoring and coaching based on motivational interviewing
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group (no cardiac rehabilitation)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Home-based mobile cardiac rehabilitation (MCR)
Number of subjects: 179
Study: 32174633

Group type: EXPERIMENTAL
Intervention: Single-visit endodontic therapy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Multiple-visit endodontic therapy
Number of subjects: 65
Study: 32552530

Group type: EXPERIMENTAL
Intervention: Laughter yoga (LY) twice weekly for 8 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Routine daily activities (Control)
Number of subjects: 66
Study: 33165588

Group type: EXPERIMENTAL
Intervention: Public primary health centres
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Newborn care and immunization services
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mental health services
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Non-communicable disease (NCD) service readiness
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Availability of medicines and supplies for communicable diseases
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Availability of medicines and supplies for maternal health services
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Basic equipment availability
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Urban location of facilities and presence of a medical officer
Number of subjects: 60
Study: 33186306

Group type: EXPERIMENTAL
Intervention: Continuous CPAP through a Boussignac system
Number of subjects: 422

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 422
Study: 33491360

Group type: EXPERIMENTAL
Intervention: Role-play training
Number of subjects: 46
Study: 34619676

Group type: EXPERIMENTAL
Intervention: Moisturizer containing 10% urea and additional NMF components
Number of subjects: 66

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 66
Study: 34325019

Group type: EXPERIMENTAL
Intervention: Early cholecystectomy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control (cholecystectomy after clinical resolution)
Number of subjects: 98
Study: 35854371

Group type: EXPERIMENTAL
Intervention: Insecticide-treated eave nets (ITENs) and insecticide-treated window screens (ITWS) installed
Number of subjects: 450

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 450
Study: 33760713

Group type: EXPERIMENTAL
Intervention: Accelerated speaking valve placement (⩽24 h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard speaking valve placement (⩾48 h)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both arms (Accelerated and Standard)
Number of subjects: 20
Study: 35656475

Group type: EXPERIMENTAL
Intervention: Bacterial cellulose (BC) dressing
Number of subjects: 212

Group type: COMPARATOR
Intervention: Vaseline gauze (VG) dressing
Number of subjects: 212
Study: 34344427

Group type: EXPERIMENTAL
Intervention: Green tea extract (450 mg, two capsules twice a day for 14 days)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (two capsules twice a day for 14 days)
Number of subjects: 74
Study: 36096458

Group type: EXPERIMENTAL
Intervention: Anodal tDCS intervention (1.5 mA for 20 min)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS intervention
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 15
Study: 34213544

Group type: EXPERIMENTAL
Intervention: High-dose prenatal plus postpartum vitamin D (28,000 IU per week)
Number of subjects: 1174

Group type: COMPARATOR
Intervention: Placebo (0 IU vitamin D per week)
Number of subjects: 1174
Study: 35452918

Group type: EXPERIMENTAL
Intervention: Accelerated access to physiotherapy
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Personalised approach with a physiotherapist who actively listened and provided a bespoke multimodal regimen
Number of subjects: 33
Study: 32130184

Group type: EXPERIMENTAL
Intervention: Nurse coaching and mobile health (mHealth) technology
Number of subjects: 319

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 319
Study: 33672229

Group type: EXPERIMENTAL
Intervention: BeFAB app (n = 65)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Usual care (n = 71)
Number of subjects: 136
Study: 32853703

Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control (prerecorded electroencephalograms with participant's artifacts)
Number of subjects: 144
Study: 33491110

Group type: EXPERIMENTAL
Intervention: Emdogain (Straumann, Basel, Switzerland)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Curodont Repair (Credentis AG, Switzerland)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Duraphat (Colgate‐Palmolive, New York, NY)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clinpro XT (3 M ESPE, Pymble, New South Wales, Australia)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Enamel Pro Varnish (Premier Dental Products, PA, USA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 60
Study: 34246303

Group type: EXPERIMENTAL
Intervention: LOW (1.5 g/kg carbohydrate, 3.0 g/kg fat)
Number of subjects: 11

Group type: COMPARATOR
Intervention: AD (6.0 g/kg carbohydrate, 1.0 g/kg fat)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: LOW
Number of subjects: 11

Group type: COMPARATOR
Intervention: AD
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both LOW and AD
Number of subjects: 11
Study: 35410284

Group type: EXPERIMENTAL
Intervention: Mindfulness-based interventions (MBIs)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Relaxation interventions
Number of subjects: 135

Group type: COMPARATOR
Intervention: No session-introducing intervention
Number of subjects: 135
Study: 33256456

Group type: EXPERIMENTAL
Intervention: Real TEAS at PC6 for 20 min at 2 Hz frequency and 6 mA intensity
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham TEAS (control) with zero frequency/intensity
Number of subjects: 32
Study: 32179929

Group type: EXPERIMENTAL
Intervention: Intensive rehabilitation programme in a warm climate (17-day duration)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual care with no structured rehabilitation
Number of subjects: 64